THE US Drug Enforcement Administration dealt a major blow to science with its decision to preserve the National Institute on Drug Abuse's monopoly on the supply of marijuana available for FDA-approved research (" UMass loses marijuana lab bid ," Health/Science, Jan. 13). The decision is an inappropriate injection of political ideology into what should properly be a question of science. (Full article: 200 words)

This article is available in our archives: Globe Subscribers FREE for subscribers Subscribers to the Boston Globe get unlimited access to our archives. Not a subscriber? Non-Subscribers Purchase an electronic copy of the full article. Learn More $9.95 1 month archives pass

1 month archives pass $24.95 3 months archives pass

3 months archives pass $74.95 1 year archives pass